US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist
  • 4.780
  • +0.150+3.24%
Close Dec 20 16:00 ET
  • 4.780
  • 0.0000.00%
Post 20:01 ET
278.71MMarket Cap-16.48P/E (TTM)

About Vanda Pharmaceuticals Company

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Company Profile

SymbolVNDA
Company NameVanda Pharmaceuticals
Listing DateApr 12, 2006
Issue Price10.00
Founded2002
CEODr. Mihael Hristos Polymeropoulos,M.D.
MarketNASDAQ
Employees203
Fiscal Year Ends12-31
Address2200 Pennsylvania Avenue NW,Suite 300E
CityWashington
ProvinceDistrict of Columbia
CountryUnited States of America
Zip Code20037
Phone1-202-734-3400

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mihael Hristos Polymeropoulos,M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 3.72M
  • Kevin Moran
  • Senior Vice President, Principal Accounting Officer, Chief Financial Officer and Treasurer
  • 1.32M
  • Joakim Wijkstrom
  • Senior Vice President and Chief Marketing Officer
  • 1.36M
  • Timothy Williams
  • Senior Vice President, General Counsel and Secretary
  • 1.40M
  • Gunther Birznieks
  • Senior Vice President, Business Development
  • 1.37M
  • Phaedra Chrousos
  • Independent Director
  • 300.00K
  • Richard W. Dugan
  • Lead Independent Director
  • 332.50K
  • Anne Sempowski Ward
  • Independent Director
  • 302.50K
  • Tage Honore
  • Independent Director
  • 602.43K
  • Stephen Ray Mitchell
  • Independent Director
  • 282.50K
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.